The European Health Catapult Competition reached its climax on 5 December at the EIT Health Summit in London, where a jury of experts announced the winning start-ups in the Medtech, Biotech and Digital Health categories. Following a year of training and competition, the top 21 of the original 42 start-ups that were accepted for theRead more about RAS-Q wins EIT Health catapult medtech finals 2017[…]
Read more RAS-Q wins EIT Health catapult medtech finals 2017
Background
Pulmonary disease is one of the leading causes of death worldwide. 9,5 million deaths during 2008 were caused by lung infections, lung cancer and chronic obstructive pulmonary diseases (COPD). Common reasons for lung diseases are smoking, air pollution as well as influenzas or genetics.
COPD is the most common chronic respiratory disease, also known as smoker lung. In the beginning stages of COPD, patients suffer from shortness of breath. End-stage COPD patients need invasive ventilation or tracheotomy, which highly restricts their quality of life, mobility and ability to communicate.